<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>07649995954160</udiDi>
    <basicUdiDi>7649995954PMBRAFIVDRTQ</basicUdiDi>
    <tradeName>Oncobit PM BRAF V600K Control 50rxn</tradeName>
    <deviceName>Oncobit PM BRAFV600</deviceName>
    <manufacturerName>Oncobit AG</manufacturerName>
    <manufacturerSrn>CH-MF-000037436</manufacturerSrn>
    <authorisedRepresentativeName>MedEnvoy Global BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000024028</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PM-1-01-02-2</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:14:48.091Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649995954153</udiDi>
    <basicUdiDi>7649995954PMBRAFIVDRTQ</basicUdiDi>
    <tradeName>Oncobit PM BRAF V600K PPM 200rxn</tradeName>
    <deviceName>Oncobit PM BRAFV600</deviceName>
    <manufacturerName>Oncobit AG</manufacturerName>
    <manufacturerSrn>CH-MF-000037436</manufacturerSrn>
    <authorisedRepresentativeName>MedEnvoy Global BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000024028</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PM-1-01-02-1</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:14:46.893Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649995954146</udiDi>
    <basicUdiDi>7649995954PMBRAFIVDRTQ</basicUdiDi>
    <tradeName>Oncobit PM BRAF V600E2 Control 10rxn</tradeName>
    <deviceName>Oncobit PM BRAFV600</deviceName>
    <manufacturerName>Oncobit AG</manufacturerName>
    <manufacturerSrn>CH-MF-000037436</manufacturerSrn>
    <authorisedRepresentativeName>MedEnvoy Global BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000024028</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PM-1-01-04-2</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:14:40.886Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649995954139</udiDi>
    <basicUdiDi>7649995954PMBRAFIVDRTQ</basicUdiDi>
    <tradeName>Oncobit PM BRAF V600E2 PPM 40rxn</tradeName>
    <deviceName>Oncobit PM BRAFV600</deviceName>
    <manufacturerName>Oncobit AG</manufacturerName>
    <manufacturerSrn>CH-MF-000037436</manufacturerSrn>
    <authorisedRepresentativeName>MedEnvoy Global BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000024028</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PM-1-01-04-1</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:14:39.687Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649995954122</udiDi>
    <basicUdiDi>7649995954PMBRAFIVDRTQ</basicUdiDi>
    <tradeName>Oncobit PM BRAF V600E Control 50rxn</tradeName>
    <deviceName>Oncobit PM BRAFV600</deviceName>
    <manufacturerName>Oncobit AG</manufacturerName>
    <manufacturerSrn>CH-MF-000037436</manufacturerSrn>
    <authorisedRepresentativeName>MedEnvoy Global BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000024028</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PM-1-01-01-2</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:14:38.508Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649995954115</udiDi>
    <basicUdiDi>7649995954PMBRAFIVDRTQ</basicUdiDi>
    <tradeName>Oncobit PM BRAF V600E PPM 200rxn</tradeName>
    <deviceName>Oncobit PM BRAFV600</deviceName>
    <manufacturerName>Oncobit AG</manufacturerName>
    <manufacturerSrn>CH-MF-000037436</manufacturerSrn>
    <authorisedRepresentativeName>MedEnvoy Global BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000024028</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PM-1-01-01-1</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:14:37.294Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649995954030</udiDi>
    <basicUdiDi>7649995954PMAnalyzerGE</basicUdiDi>
    <tradeName>Oncobit PM Analyzer</tradeName>
    <deviceName>Oncobit PM Analyzer</deviceName>
    <manufacturerName>Oncobit AG</manufacturerName>
    <manufacturerSrn>CH-MF-000037436</manufacturerSrn>
    <authorisedRepresentativeName>MedEnvoy Global BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000024028</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PM-2-00-00-3</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:14:31.291Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649995954016</udiDi>
    <basicUdiDi>7649995954PMAnalyzerGE</basicUdiDi>
    <tradeName>Oncobit PM Analyzer</tradeName>
    <deviceName>Oncobit PM Analyzer</deviceName>
    <manufacturerName>Oncobit AG</manufacturerName>
    <manufacturerSrn>CH-MF-000037436</manufacturerSrn>
    <authorisedRepresentativeName>MedEnvoy Global BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000024028</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PM-2-00-00-3</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:14:30.088Z</lastUpdated>
  </row>
</eudamedExport>